Automated Cell Culture Market Regional Analysis:
North American Market Insights
The North America automated cell culture market is projected to be the largest with a revenue share of 43% by the end of 2035. The need for customized medication, the amount of research and development being done on cancer, and the existence of major rivals in the industry are all factors contributing to the growth of the automated cell culture market. An estimated 1.9 million new instances of cancer will be identified in the US in 2021, and 608,570 people will die from cancer. The market is growing as a result of developing biotechnology sectors, better cell culture technology systems, and an increased need for cell culture technology in the production of vaccines. The growing cost of healthcare is driving up demand in the market in the region. Medical research is supported by the government since healthcare is one of the main goals in the United States. Growing government funding for cell-based research is one of the main factors propelling the market's growth.
European Market Insights
The Europe automated cell culture market share is estimated to cross 25% by 2035. The European market for automated cell culture is growing rapidly due to increased government support from important countries such as Russia, Germany, the United Kingdom, and Spain. Research activity in the region is also stimulated by rising R&D spending in the main European countries. For instance, the UK government announced in March 2020 the highest-ever research and development budget of USD 50.04 billion. The increasing demand for customized treatments, coupled with population aging and the advancement of new production techniques, is one of the primary factors propelling the pharmaceutical industry's growth in Europe. These factors also tend to increase the region's need for automated cell culture.
